SYX-5219 Oral Capsule Clinical Trials (2026): 1 Studies for Moderate to Severe Atopic Dermatitis
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 SYX-5219 Oral Capsule clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Moderate to Severe Atopic Dermatitis) and 149 total planned enrollment. 1 SYX-5219 Oral Capsule clinical trial is actively recruiting at 6 U.S. sites across 6 states. Most recent activity: NCT07558668 (Sep 2026).
Where to Participate: All SYX-5219 Oral Capsule Trial Sites in the U.S. (6 sites across 6 states)
Every actively recruiting SYX-5219 Oral Capsuletrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AR | Sitryx Clinical Site | Arkansas City72117 | NCT07558668 | Map |
| CA | Sitryx Clinical Site | Fremont94538 | NCT07558668 | Map |
| IN | Sitryx Clinical Site | Plainfield46168 | NCT07558668 | Map |
| OH | Sitryx Clinical Site | Boardman44512 | NCT07558668 | Map |
| PA | Sitryx Clinical Site | Philadelphia19103 | NCT07558668 | Map |
| UT | Sitryx Clinical Site | Bountiful84010 | NCT07558668 | Map |
SYX-5219 Oral Capsule clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting SYX-5219 Oral Capsule clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07558668 | A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis | P1 | Moderate to Severe Atopic Dermatitis | 149 | Feb 2025 |
All SYX-5219 Oral Capsule trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07558668 | A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis | P1 | recruiting | 149 | Sitryx Therapeutics Ltd | Feb 2025 |
SYX-5219 Oral Capsule clinical trials: frequently asked questions
- How many SYX-5219 Oral Capsule clinical trials are there?
- 1 SYX-5219 Oral Capsule clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are SYX-5219 Oral Capsule clinical trials recruiting in 2026?
- Yes — 1 SYX-5219 Oral Capsule trial is actively recruiting in 2026, with 6 U.S. sites across 6 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is SYX-5219 Oral Capsule being studied for?
- SYX-5219 Oral Capsule is being studied for Moderate to Severe Atopic Dermatitis. The trials are grouped by indication on this page.
- What phase is SYX-5219 Oral Capsule in?
- SYX-5219 Oral Capsule clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors SYX-5219 Oral Capsule clinical trials?
- The lead sponsor across the most SYX-5219 Oral Capsule trials is Sitryx Therapeutics Ltd. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming SYX-5219 Oral Capsuleas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: